Publications by authors named "Michael Hopfner"

Claim this Profile
W
Why is ultrasound needed in inflammatory bowel disease?
Frauke Petersen, Michael Höpfner Höpfner, Christian Jenssen, Dieter Nürnberg, Deike Strobel

Med Ultrason· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global impact of anthropogenic NH emissions on upper tropospheric aerosol formation.
Christos Xenofontos, Matthias Kohl, Samuel Ruhl, João Almeida, Lucía Caudillo-Plath

Proc Natl Acad Sci U S A· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasound for detection of complications and evaluation of treatment response in inflammatory bowel disease (IBD)?
Christoph F Dietrich, Frauke Petersen, Michael Höpfner, Dieter Nürnberg, Deike Strobel

Med Ultrason· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why and when are activity scores and advanced ultrasound techniques needed in inflammatory bowel disease (IBD)?
Christian Jenssen, Frauke Petersen, Michael Höpfner, Dieter Nürnberg, Deike Strobel

Med Ultrason· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a New Pentafluorosulfanyl-Substituted Chalcone with Activity Against Hepatoma and Human Parasites.
Alessandra Viperino, Michael Höpfner, Nicole Edel, Ibrahim S Al Nasr, Waleed S Koko

Pharmaceuticals (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone deacetylases in the regulation of cell death and survival mechanisms in resistant BRAF-mutant cancers.
Bernhard Biersack, Bianca Nitzsche, Michael Höpfner

Cancer Drug Resist· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging role of MYB transcription factors in cancer drug resistance.
Bernhard Biersack, Michael Höpfner

Cancer Drug Resist· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory properties of HDAC6 inhibitors in cancer diseases: New chances for sophisticated drug design and treatment optimization.
Bernhard Biersack, Bianca Nitzsche, Michael Höpfner

Semin Cell Dev Biol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of the new tyrphostin briva against BRAF-mutant colorectal carcinoma cells.
Khaled Saleh, Mai Al Sakhen, Sana Kanaan, Salem Yasin, Michael Höpfner

Invest New Drugs· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-ovo echocardiography for application in cardiovascular research.
Niklas Hegemann, Willem Bintig, Paul-Lennard Perret, Judith Rees, Alessandra Viperino

Basic Res Cardiol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New chimeric HDAC inhibitors for the treatment of colorectal cancer.
Sofia I Bär, Rohan Pradhan, Bernhard Biersack, Bianca Nitzsche, Michael Höpfner

Arch Pharm (Weinheim)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic Small Molecule Modulators of Hsp70 and Hsp40 Chaperones as Promising Anticancer Agents.
Bianca Nitzsche, Michael Höpfner, Bernhard Biersack

Int J Mol Sci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Anticancer Evaluation of New Indole-Based Tyrphostin Derivatives and Their (-Cymene)dichloridoruthenium(II) Complexes.
Natalie Oberhuber, Hindole Ghosh, Bianca Nitzsche, Prasad Dandawate, Michael Höpfner

Int J Mol Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Advances in molecular targeted therapies of urologic cancers.
Bianca Nitzsche, Michael Höpfner

Front Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer properties of chimeric HDAC and kinase inhibitors.
Bernhard Biersack, Sibel Polat, Michael Höpfner

Semin Cancer Biol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric HDAC and the cytoskeleton inhibitor broxbam as a novel therapeutic strategy for liver cancer.
Sofia Isolde Bär, Alexandra Dittmer, Bianca Nitzsche, Gohar Ter-Avetisyan, Michael Fähling

Int J Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Thienyl-Based Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma.
Andi Ma, Bernhard Biersack, Nils Goehringer, Bianca Nitzsche, Michael Höpfner

J Pers Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HDAC inhibitors with potential to overcome drug resistance in castration-resistant prostate cancer.
Bernhard Biersack, Bianca Nitzsche, Michael Höpfner

Cancer Drug Resist· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Anticancer Activities of a New Pentafluorothio-Substituted Vorinostat-Type Histone Deacetylase Inhibitor.
Nils Goehringer, Yayi Peng, Bianca Nitzsche, Hannah Biermann, Rohan Pradhan

Pharmaceuticals (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasound findings in peliosis hepatis.
Yi Dong, Wen-Ping Wang, Adrian Lim, Won Jae Lee, Dirk-Andre Clevert

Ultrasonography· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer Activity and Mechanisms of Action of New Chimeric EGFR/HDAC-Inhibitors.
Nils Goehringer, Bernhard Biersack, Yayi Peng, Rainer Schobert, Marco Herling

Int J Mol Sci· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New 3-Aryl-2-(2-thienyl)acrylonitriles with High Activity Against Hepatoma Cells.
Eva Schaller, Andi Ma, Lisa Chiara Gosch, Adrian Klefenz, David Schaller

Int J Mol Sci· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photodynamic therapy of hepatocellular carcinoma using tetra-triethyleneoxysulfonyl zinc phthalocyanine as photosensitizer.
Racheal O Ogbodu, Bianca Nitzsche, Andi Ma, Devrim Atilla, Ayşe Gül Gürek

J Photochem Photobiol B· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gap junctions regulate vessel diameter in chick chorioallantoic membrane vasculature by both tone-dependent and structural mechanisms.
Martin Maibier, Willem Bintig, Andrean Goede, Michael Höpfner, Wolfgang M Kuebler

Microcirculation· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor and antiangiogenic activity of the novel chimeric inhibitor animacroxam in testicular germ cell cancer.
Gustav Steinemann, Alexandra Dittmer, Jacob Schmidt, David Josuttis, Michael Fähling

Mol Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis